Lead: Murat Guvendiren
Partner: Dave Washburn, Chief Operating Officer, Acuitive Technologies, Allendale, NJ 07401
Amount: $25000
Intellectual Property Status: Invention disclosure
Award Date: 09/01/2024
End Date: 06/01/2025
ABSTRACT
This highly transformative proposed project addresses the unmet need for restorative treatments of large bone defects by developing novel bone allograft composite ink formulations to 3D print bone grafts designed from patient’s medical images.
This is not the NSF website for the ART program. The development of this portal is supported by the U.S. National Science Foundation under Award No. 2331429. The material on this portal is sourced from the various activities and projects being supported the ART program. Any opinions, findings and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the U.S. National Science Foundation.
